Delivery Order SPE2DB24D2205-SPE2DB24FDWAK
Award Date
6/25/24
Potential Completion Date
6/26/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen. The award, valued at $5,155.20, is a firm-fixed-price contract with a performance period ending on May 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company. The contract is a Delivery Order valued at $1,895.56 for the supply of the prescription drug Mounjaro (tirzepatide) 10 mg/0.5 mL pen. The contract has an ultimate completion date of May 17, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support...
This federal contract award is to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor, to supply the Defense Logistics Agency (DLA) Troop Support Medical with the drug Mounjaro (Tirzepatide) 10 mg/0.5 mL pens. The delivery order is valued at $9,226.10 and has a completion date of September 18, 2024. This contract is not set aside for a specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Mounjaro (tirzepatide) 7.5 mg/0.5 ml pens. The $1,578 Firm Fixed Price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract has an ultimate completion date of August 5, 2024 and does not utilize any set-aside designations. As a large medical supplier, Amerisourcebergen has...
This federal contract award from the Defense Logistics Agency (DLA) was issued to the pharmaceutical distribution company Amerisourcebergen Drug Corp (Amerisourcebergen) to provide the drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. The $1,841.00 firm-fixed-price delivery order has an ultimate completion date of August 20, 2024. Amerisourcebergen is the prime contractor for this contract, which does not have a set-aside designation. This award is likely part of a larger Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a $9,319.47 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of the prescription drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under contract SPE2DB20D2104|SPE2DB25FMCPD. The $1,533.35 firm fixed-price delivery order is for the supply of the medication Mounjaro (tirzepatide) 5 mg/0.5 mL pens to support federal healthcare programs. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,678.51, is for the delivery of the medication Mounjaro (tirzepatide) 5 mg/0.5 mL pens. This is a firm fixed-price delivery order contract with a completion date of May 24, 2024. The contract was awarded on May 23, 2024 and does not have a set-aside designation, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Mounjaro (tirzepatide) 7.5 mg/0.5 ml pen with a total ceiling value of $3,509.92. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 21, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $9,954.88 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of the drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical...